Andrés García León, MD

Head of Angiology and Vascular Surgery Department
Hospital Universitario Virgen de Valme
Sevilla, Andalucia, Spain

Bachelor of Medicine. Universidad Autónoma de Barcelona. 1995-2001.
Angiology and Vascular Surgery specialization. Hospital del Mar. Barcelona. 2002-2007.
Higher Specialized Studies (DESS) in Surgery. 2007.
Master in Methodology of Investigation in Health Sciences. 2013.
Expert Degree in Health Management. 2014.
Expert Degree in Interventional Vascular Radiology. 2017.
Good Clinical Practices ICH E6 (R2) Certificate, 2024.

ACTUAL SITUATION
Head of Angiology and Vascular Surgery Department, University Hospital of Virgen de Valme, Sevilla, Spain.
Adjunct Professor, Surgery Department, Medicine Faculty, University of Sevilla.

Member of:
● American Venous Forum
● European Society of Vascular Surgery
● Sociedad Española de Angiología y Cirugía Vascular. SEACV
● Capítulo de Cirugía Endovascular de la SEACV.
● Capítulo Español de Flebología y Linfología de la SEACV. Board member
● Sociedad Andaluza de Angiología y Cirugía Vascular. Board Member.
● Real e Ilustre Colegio Oficial de Médicos de Sevilla. Expert Comitee in Angiology and Vascular Surgery.
● Medical licence number: 410836573

Involved in several aspects of medical education:
Programa de Formación Sanitaria Especializada en Angiología y Cirugía Vascular.
Adjunct Professor in Angiology and Vascular Surgery, Surgery Department, Medicine Faculty, University of Sevilla.

Professor:
● "Máster en Angiología y Cirugía Vascular. Procedimientos de Embolización" 2021-2022, 2023-2024, 2024-2025 del CCEV de la SEACV. Universidad Europea Miguel de Cervantes.
● "Máster de Flebología clínica y abordaje de las alteraciones estéticas del miembro inferior" del CEFyL de la SEACV. Universidad Europea. 2020-2021, 2022-2023, 2025-2026.
● Formación Avanzada en Técnicas de Embolización, IAVANTE-CMAT, Granada. 2014, 2015, 2016 y 2017. Coordinador y profesor.
● Formación Avanzada en Técnicas Endovasculares Periféricas, CMAT Granada 2017, 2018 y 2019. Coordinador y profesor.

INVESTIGATION:
Phase I open-label, first-in-human study to evaluate feasibility and safety of tissue engineered veins in patients with chronic venous insufficiency. Id: NCT03784131. Principal Investigator.

Disclosure information not submitted.

Presentation(s):

• Phase I, open-label, first-in-human study to evaluate the safety and feasibility of personalized tissue-engineered vein grafts in patients with chronic venous insufficiency.

  Wednesday, February 19, 2025
  11:32 AM – 11:38 AM